11 Spinal Muscular Atrophy Clinical Trials in Goodyear, AZ (2026)

Q: How do I join a clinical trial in Goodyear?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Goodyear research site will contact you.

Recruiting Spinal Muscular Atrophy Studies in Goodyear

NCT03851445Recruiting

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to ...

Goodyear, AZPHASE210,000 participantsSWOG Cancer Research Network

View Study Details

NCT07222566Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with chemotherapy) for adults w...

Goodyear, AZPHASE31,410 participantsPfizer

View Study Details

NCT06095583Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

The Study is a Phase 3, randomized, three-arm, double-blind, placebo-controlled, multi-regional clinical research study to evaluate the safety and efficacy use of toripalimab alone or in combination w...

Goodyear, AZPHASE3756 participantsShanghai Junshi Bioscience Co., Ltd.

View Study Details

NCT04613596Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and ...

Goodyear, AZPHASE2626 participantsMirati Therapeutics Inc.

View Study Details

NCT07288034Recruiting

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

This phase II trial tests the impact of biomarkers in predicting initial treatment (first-line) PD1 or PD-L1 (PD\[L\]-1)-based immunotherapy response and in selecting second-line treatment in patients...

Goodyear, AZPHASE2535 participantsCity of Hope Medical Center

View Study Details

NCT07365241Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sites including mediastinal lymph nodes, liver, bones, adrenal glands, a...

Goodyear, AZPHASE3531 participantsAbbVie

View Study Details

NCT06667076Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

The primary purpose of the study is to assess how well amivantamab in combination with lazertinib or in combination with chemotherapy works (antitumor activity) in participants with epidermal growth f...

Goodyear, AZPHASE2480 participantsJanssen Research & Development, LLC

View Study Details

NCT07291037Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

TROPION-Lung17 will measure the efficacy and safety of datopotamab deruxtecan (Dato-DXd) compared with docetaxel in patients with trophoblast cell surface protein 2 (TROP2) positive advanced or metast...

Goodyear, AZPHASE3400 participantsAstraZeneca

View Study Details

NCT07005128Recruiting

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

The main objective of the study is to compare the efficacy of tarlatamab in combination with durvalumab, carboplatin and etoposide to the combination of durvalumab, carboplatin and etoposide on prolon...

Goodyear, AZPHASE3330 participantsAmgen

View Study Details

NCT07154290Recruiting

A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

This study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metastatic Non-Small Cell Lung Cancer (NSCLC), and sarilumab, to evaluate to see if i...

Goodyear, AZPHASE2300 participantsRegeneron Pharmaceuticals

View Study Details

NCT07531095Recruiting

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

The primary objective of this trial is to evaluate the safety and tolerability of tarlatamab in combination with ZL-1310 with or without durvalumab and to determine the maximum tolerated combination d...

Goodyear, AZPHASE1160 participantsAmgen

View Study Details

About Spinal Muscular Atrophy Clinical Trials in Goodyear

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 11 spinal muscular atrophy clinical trials recruiting participants in Goodyear, AZ. These studies are seeking a combined 15,528 participants. Research is being sponsored by SWOG Cancer Research Network, Pfizer, Shanghai Junshi Bioscience Co., Ltd. and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Goodyear — FAQ

Are there spinal muscular atrophy clinical trials in Goodyear?

Yes, there are 11 spinal muscular atrophy clinical trials currently recruiting in Goodyear, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Goodyear?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Goodyear research site will contact you about next steps.

Are clinical trials in Goodyear free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Goodyear studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 11 active trials in Goodyear are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated September 6, 2026 from ClinicalTrials.gov